Collegium Pharmaceutical Inc (COLL)

Return on total capital

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Earnings before interest and tax (EBIT) (ttm) US$ in thousands 172,542 198,610 214,187 209,163 159,072 105,865 76,792 48,247 34,366 -12,537 -18,863 -13,566 17,640 66,758 72,235 72,386 56,464 39,379 13,869 -7,170
Long-term debt US$ in thousands — — — — — — — — — — — — — — — — — — — —
Total stockholders’ equity US$ in thousands 1,663,590 234,279 216,583 222,169 195,431 178,873 200,805 179,733 194,842 197,194 197,612 196,076 202,928 251,094 253,066 170,035 186,031 172,686 155,767 141,063
Return on total capital 10.37% 84.77% 98.89% 94.15% 81.40% 59.18% 38.24% 26.84% 17.64% -6.36% -9.55% -6.92% 8.69% 26.59% 28.54% 42.57% 30.35% 22.80% 8.90% -5.08%

December 31, 2024 calculation

Return on total capital = EBIT (ttm) ÷ (Long-term debt + Total stockholders’ equity)
= $172,542K ÷ ($—K + $1,663,590K)
= 10.37%

Collegium Pharmaceutical Inc's return on total capital has fluctuated over the period from March 31, 2020, to December 31, 2024. The company experienced negative returns at the beginning of the period, with -5.08% in March 2020, and -6.92% in March 2022. However, the return improved significantly reaching its peak at 98.89% in June 30, 2024, before declining to 10.37% in December 31, 2024.

Overall, the return on total capital exhibited volatility, with both high and low points. It is important to further investigate the factors contributing to these fluctuations to understand Collegium Pharmaceutical Inc's financial performance.